semaglutide for type 1 diabetes and tirzepatide treatment leads to weight loss in Can Type 1 and Type

Existing research is promising for some options, and fairly limited for others

The most important distinction is between Hashimoto's thyroiditis (an autoimmune condition causing hypothyroidism) and medullary thyroid carcinoma (a rare thyroid cancer arising from C-cells), as these represent entirely different thyroid pathologies with different implications for GLP-1 use

The Journal of Nutrition, 150(10), 26282634

Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1

Available from: Bettge K, Kahle M, Abd El Aziz MS, Meier JJ, Nauck MA (2017) Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials